872 related articles for article (PubMed ID: 16421367)
21. [Prophylactic surgery in common hereditary cancer syndromes].
Noguès C; Mouret-Fourme E
Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
[TBL] [Abstract][Full Text] [Related]
22. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
[TBL] [Abstract][Full Text] [Related]
23. Prophylactic Risk-reducing Hysterectomies and Bilateral Salpingo-oophorectomies in Patients With Lynch Syndrome: A Clinicopathologic Study of 29 Cases and Review of the Literature.
Fedda FA; Euscher ED; Ramalingam P; Malpica A
Int J Gynecol Pathol; 2020 Jul; 39(4):313-320. PubMed ID: 31851061
[TBL] [Abstract][Full Text] [Related]
24. Hereditary non-polyposis colorectal cancer or Lynch syndrome: the gynaecological perspective.
Manchanda R; Menon U; Michaelson-Cohen R; Beller U; Jacobs I
Curr Opin Obstet Gynecol; 2009 Feb; 21(1):31-8. PubMed ID: 19125001
[TBL] [Abstract][Full Text] [Related]
25. [Prophylactic hysterectomy in Lynch syndrome: Feasibility and outcomes].
Pacelli J; Gosset M; Rossi L; Ngo C; Delomenie M; Nos C; Lécuru F; Bats AS
Gynecol Obstet Fertil Senol; 2019 Jun; 47(6):497-503. PubMed ID: 31003015
[TBL] [Abstract][Full Text] [Related]
26. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
27. Screening and prevention of hereditary gynecologic cancers.
Kehoe SM; Kauff ND
Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
[TBL] [Abstract][Full Text] [Related]
28. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
Meiser B; Butow P; Barratt A; Friedlander M; Gattas M; Kirk J; Suthers G; Walpole I; Tucker K
Gynecol Oncol; 1999 Oct; 75(1):122-9. PubMed ID: 10502438
[TBL] [Abstract][Full Text] [Related]
29. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.
Callahan MJ; Crum CP; Medeiros F; Kindelberger DW; Elvin JA; Garber JE; Feltmate CM; Berkowitz RS; Muto MG
J Clin Oncol; 2007 Sep; 25(25):3985-90. PubMed ID: 17761984
[TBL] [Abstract][Full Text] [Related]
30. [Indications for prophylactic hysterectomy].
Garabedian C; Lejeune S; Merlot B; Kerdraon O; Boulanger L; Collinet P
Gynecol Obstet Fertil; 2013 Oct; 41(10):620-3. PubMed ID: 24120286
[TBL] [Abstract][Full Text] [Related]
31. Prophylactic Gynecologic Specimens from Hereditary Cancer Carriers.
Shaw PA; Clarke BA
Surg Pathol Clin; 2016 Jun; 9(2):307-28. PubMed ID: 27241111
[TBL] [Abstract][Full Text] [Related]
32. Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis.
Escobar PF; Starks DC; Fader AN; Barber M; Rojas-Espalliat L
Gynecol Oncol; 2010 Oct; 119(1):43-7. PubMed ID: 20579712
[TBL] [Abstract][Full Text] [Related]
33. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk.
Parazzini F; Negri E; La Vecchia C; Luchini L; Mezzopane R
Obstet Gynecol; 1993 Mar; 81(3):363-6. PubMed ID: 8437787
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing JP; Watson P; Easton DF; Ponder BA; Lynch HT; Tucker MA
J Natl Cancer Inst Monogr; 1995; (17):33-5. PubMed ID: 8573450
[TBL] [Abstract][Full Text] [Related]
35. [Lynch syndrome and gynaecologic's cancer: follow-up recommendations].
Magri K; Millon G
J Gynecol Obstet Biol Reprod (Paris); 2007 Feb; 36(1):68-71. PubMed ID: 17293255
[TBL] [Abstract][Full Text] [Related]
36. Hysterectomy with or without unilateral oophorectomy and risk of ovarian cancer.
Chiaffarino F; Parazzini F; Decarli A; Franceschi S; Talamini R; Montella M; La Vecchia C
Gynecol Oncol; 2005 May; 97(2):318-22. PubMed ID: 15863124
[TBL] [Abstract][Full Text] [Related]
37. [Endometrial cancer in HNPCC syndrome].
Lécuru F; Ansquer Y; Bats AS; Olschwang S; Laurent-Puig P; Eisinger F
J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):547-53. PubMed ID: 18650032
[TBL] [Abstract][Full Text] [Related]
38. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
Schrag D; Kuntz KM; Garber JE; Weeks JC
N Engl J Med; 1997 May; 336(20):1465-71. PubMed ID: 9148160
[TBL] [Abstract][Full Text] [Related]
39. Incidence of ovarian cancer in women with prior hysterectomy in Japan.
Yaegashi N; Sato S; Yajima A
Gynecol Oncol; 1998 Mar; 68(3):244-6. PubMed ID: 9570974
[TBL] [Abstract][Full Text] [Related]
40. Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
Stuckless S; Green J; Dawson L; Barrett B; Woods MO; Dicks E; Parfrey PS
Clin Genet; 2013 Apr; 83(4):359-64. PubMed ID: 22775459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
